Effect of Long-Term Proton Pump Inhibitor Use on Glycemic Control in Patients with Type Two Diabetes Mellitus
There have been conflicting results regarding the effect of proton pump inhibitors (PPIs) as an adjunctive therapy to oral antidiabetic medication (OAM) in those with type 2 diabetes (T2DM). PPIs increase gastrin levels, causing a rise in insulin. No studies have evaluated the duration of PPI therap...
Saved in:
Main Authors: | Amy Trang, Jordan Bushman, Alexandra Halalau |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2021/5578265 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deprescribing proton pump inhibitors
by: Kim Jun Kevin Teh, et al.
Published: (2023-08-01) -
Safety of proton pump inhibitors
by: Ye. A. Losik
Published: (2016-08-01) -
Proton Pump Inhibitors: How Appropriate?
by: Daniel C Sadowski
Published: (2000-01-01) -
A Patient on Long-Term Proton Pump Inhibitors Develops Sudden Seizures and Encephalopathy: An Unusual Presentation of Hypomagnesaemia
by: Nirav Y. Gandhi, et al.
Published: (2012-01-01) -
Proton pump inhibitor leaflets: Is there information on deprescribing?
by: Marcus Vinícius Lopes Campos, et al.
Published: (2025-01-01)